Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials

Lehmann, Lutz E; Herpichboehm, Bernd; Kost, Gerald J; Kollef, Marin H; Stüber, Frank (2010). Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Critical care, 14(5), R186. London: BioMed Central 10.1186/cc9294

[img]
Preview
Text
cc9294.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (599kB) | Preview

Delays in adequate antimicrobial treatment contribute to high cost and mortality in sepsis. Polymerase chain reaction (PCR) assays are used alongside conventional cultures to accelerate the identification of microorganisms. We analyze the impact on medical outcomes and healthcare costs if improved adequacy of antimicrobial therapy is achieved by providing immediate coverage after positive PCR reports.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic and Policlinic for Anaesthesiology and Pain Therapy

UniBE Contributor:

Lehmann, Lutz Eric and Stüber, Frank

ISSN:

1364-8535

Publisher:

BioMed Central

Language:

English

Submitter:

Jeannie Wurz

Date Deposited:

04 Oct 2013 14:08

Last Modified:

23 Jan 2018 12:17

Publisher DOI:

10.1186/cc9294

PubMed ID:

20950442

Web of Science ID:

000284596500025

BORIS DOI:

10.7892/boris.556

URI:

https://boris.unibe.ch/id/eprint/556 (FactScience: 199729)

Actions (login required)

Edit item Edit item
Provide Feedback